LGALS1 and pancreatic neoplasm: Using c-myc- or KRas-driven mouse models of PDA, and genetic depletion of Gal1 (Gal1 knockout (KO) mice), we have previously demonstrated that stromal Gal1 is a key mediator of pancreatic cancer development and progression (Table 1).